BIOLASE (BIOL) Short Interest Ratio & Short Volume → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free BIOL Stock Alerts $0.14 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media BIOLASE Short Interest DataCurrent Short Volume592,700 sharesPrevious Short Volume2,290,000 sharesChange Vs. Previous Month-74.12%Dollar Volume Sold Short$80,607.20Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares33,260,000 sharesFloat Size31,210,000 sharesShort Percent of Float1.90%Today's Trading Volume487,460 sharesAverage Trading Volume4,312,284 sharesToday's Volume Vs. Average11% Short Selling BIOLASE ? Sign up to receive the latest short interest report for BIOLASE and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIOL Short Interest Over TimeBIOL Days to Cover Over TimeBIOL Percentage of Float Shorted Over Time Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. BIOLASE Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024592,700 shares $80,607.20 -74.1%1.9%0.1 $0.14 3/31/20242,290,000 shares $434,642.00 +692.7%7.5%0.4 $0.19 3/15/2024288,900 shares $40,128.21 +17.6%0.9%0.1 $0.14 2/29/2024245,600 shares $33,892.80 -63.8%0.9%0.1 $0.14 2/15/2024678,600 shares $98,600.58 +602.5%3.1%0.5 $0.15 1/31/202496,600 shares $72,073.26 +375.9%3.0%0.3 $0.75 Get the Latest News and Ratings for BIOL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. 1/15/202420,300 shares $21,112.00 -57.4%0.6%0.1 $1.04 12/31/202347,600 shares $53,407.20 -5.2%1.5%0.2 $1.12 12/15/202350,200 shares $57,228.00 +126.1%1.6%0.2 $1.14 11/30/202322,200 shares $24,198.00 -77.9%1.1%0.1 $1.09 11/15/2023100,500 shares $127,635.00 +1,068.6%5.1%0.3 $1.27 10/31/20238,600 shares $14,448.00 -70.1%1.0%0 $1.68 10/15/202328,800 shares $48,960.00 -74.5%3.2%0.1 $1.70 9/30/2023113,000 shares $210,180.00 -59.0%12.1%0.4 $1.86 9/15/2023275,700 shares $526,587.00 +70.6%29.6%0.8 $1.91 8/31/2023161,600 shares $706,192.00 +4.9%16.2%0.7 $4.37 8/15/2023154,100 shares $947,715.00 -61.4%15.4%0.7 $6.15 7/31/2023399,400 shares $2.43 million -87.2%40.2%2.1 $6.09 7/15/20233,110,000 shares $270,259.00 -44.4%3.8%0.4 $0.09 6/30/20235,590,000 shares $395,213.00 +589.1%6.9%0.7 $0.07 6/15/2023811,200 shares $64,084.80 -61.2%1.1%0.2 $0.08 5/31/20232,090,000 shares $170,335.00 +145.4%8.0%0.6 $0.08 5/15/2023851,600 shares $183,008.84 +4.4%3.7%0.5 $0.21 4/30/2023815,700 shares $203,925.00 +219.5%4.1%0.8 $0.25 4/15/2023255,300 shares $61,833.66 +140.9%1.3%0.3 $0.24 3/31/2023106,000 shares $29,807.20 +127.0%0.5%0.2 $0.28 3/15/202346,700 shares $18,213.00 -59.2%0.2%0.1 $0.39 2/28/2023114,500 shares $58,395.00 -42.4%0.6%0.2 $0.51 2/15/2023198,900 shares $101,399.22 -29.1%1.0%0.3 $0.51 1/31/2023280,400 shares $152,313.28 -31.9%1.4%0.5 $0.54 1/15/2023411,800 shares $175,591.52 -36.7%12.8%0.9 $0.43 12/30/2022650,300 shares $422,695.00 -7.1%9.3%2.7 $0.65 12/15/2022700,100 shares $467,316.75 +108.5%10.0%5.1 $0.67 11/30/2022335,800 shares $324,382.80 +144.2%4.8%3 $0.97 11/15/2022137,500 shares $247,500.00 +8.4%2.0%1.8 $1.80 10/31/2022126,900 shares $248,724.00 -2.0%1.9%3.7 $1.96 10/15/2022129,500 shares $268,065.00 +5.0%1.9%3.9 $2.07 9/30/2022123,300 shares $299,619.00 +5.7%1.8%3.7 $2.43 9/15/2022116,700 shares $378,108.00 +6.4%1.7%3.2 $3.24 8/31/2022109,700 shares $424,539.00 -23.9%1.6%3.1 $3.87Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. BIOL Short Interest - Frequently Asked Questions What is BIOLASE's current short interest? Short interest is the volume of BIOLASE shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 592,700 shares of BIOL short. 1.90% of BIOLASE's shares are currently sold short. Learn More on BIOLASE's current short interest. What is a good short interest percentage for BIOLASE? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.90% of BIOLASE's floating shares are currently sold short. Is BIOLASE's short interest increasing or decreasing? BIOLASE saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 592,700 shares, a decrease of 74.1% from the previous total of 2,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BIOLASE's float size? BIOLASE currently has issued a total of 33,260,000 shares. Some of BIOLASE's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BIOLASE currently has a public float of 31,210,000 shares. How does BIOLASE's short interest compare to its competitors? 1.90% of BIOLASE's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BIOLASE: Sonendo, Inc. (0.68%), Alzamend Neuro, Inc. (0.30%), Shineco, Inc. (0.13%), OpGen, Inc. (1.36%), Palisade Bio, Inc. (4.12%), Synaptogenix, Inc. (3.21%), Cingulate Inc. (0.58%), Silo Pharma, Inc. (4.51%), Oragenics, Inc. (2.07%), NexImmune, Inc. (0.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BIOLASE stock? Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BIOLASE? A short squeeze for BIOLASE occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOL, which in turn drives the price of the stock up even further. How often is BIOLASE's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SONX Short Interest Data ALZN Short Interest Data SISI Short Interest Data OPGN Short Interest Data PALI Short Interest Data SNPX Short Interest Data CING Short Interest Data SILO Short Interest Data OGEN Short Interest Data NEXI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIOL) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society